Health Care [ 3/12 ] | Health Care Equipment & Supplies [ 22/74 ]
NASDAQ | Common Stock
Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States and internationally.
It operates in two segments, Cardiovascular and Endoscopy.
The company provides micropuncture kits, angiographic needles, sheaths, guide wires, and safety products; peripheral intervention, including angiography, drainage, delivery systems, and embolotherapy products; spine products, such as vertebral augmentation, radiofrequency ablation, and bone biopsy systems; oncology products; and cardiac intervention products, such as access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention to treat various heart conditions.
It also offers custom procedural solutions that include critical care products, disinfection protection systems, syringes, manifold kits, and trays and packs; coating services for medical tubes and wires; and sensor components for microelectromechanical systems.
In addition, the company provides pulmonary products that consist of laser-cut tracheobronchial stents, over-the-wire and direct visualization delivery systems, and dilation balloons to endoscopically dilate structures; gastroenterology products, such as covered esophageal stents, syringe and gauges, and balloon dilators; and kits and accessories for endoscopy and bronchoscopy procedures.
It sells its products to hospitals and alternate site-based physicians, technicians, and nurses through direct sales force, distributors, original equipment manufacturer partners, or custom procedure tray manufacturers.
The company was incorporated in 1987 and is headquartered in South Jordan, Utah.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Oct 30, 24 | 0.86 Increased by +14.67% | 0.80 Increased by +7.50% |
| Aug 1, 24 | 0.92 Increased by +13.58% | 0.87 Increased by +5.75% |
| Apr 30, 24 | 0.77 Increased by +20.31% | 0.71 Increased by +8.45% |
| Feb 28, 24 | 0.81 Increased by +2.53% | 0.77 Increased by +5.19% |
| Oct 26, 23 | 0.75 Increased by +17.19% | 0.65 Increased by +15.38% |
| Jul 25, 23 | 0.81 Increased by +10.96% | 0.75 Increased by +8.00% |
| Apr 26, 23 | 0.64 Increased by +20.75% | 0.55 Increased by +16.36% |
| Feb 22, 23 | 0.79 Increased by +11.27% | 0.67 Increased by +17.91% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Sep 30, 24 | 339.85 M Increased by +7.81% | 28.44 M Increased by +10.10% | Increased by +8.37% Increased by +2.13% |
| Jun 30, 24 | 337.58 M Increased by +5.47% | 35.73 M Increased by +76.47% | Increased by +10.58% Increased by +67.31% |
| Mar 31, 24 | 323.51 M Increased by +8.72% | 28.24 M Increased by +36.41% | Increased by +8.73% Increased by +25.47% |
| Dec 31, 23 | 323.29 M Increased by +10.18% | 27.63 M Decreased by -17.28% | Increased by +8.55% Decreased by -24.92% |
| Sep 30, 23 | 315.23 M Increased by +9.77% | 25.83 M Increased by +69.16% | Increased by +8.20% Increased by +54.10% |
| Jun 30, 23 | 320.06 M Increased by +8.50% | 20.25 M Increased by +32.34% | Increased by +6.33% Increased by +21.97% |
| Mar 31, 23 | 297.56 M Increased by +8.04% | 20.70 M Increased by +96.33% | Increased by +6.96% Increased by +81.72% |
| Dec 31, 22 | 293.42 M Increased by +5.36% | 33.40 M Increased by +62.04% | Increased by +11.38% Increased by +53.80% |